Skip to content
10-Q

Quarterly Report

CANCER CAPITAL CORP.

0001554795-22-000364

← back to feed
Filed
Nov 3, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 3, 2022 6.15M sh
Cash And Equivalents Q3 2022 · Sep 30, 2022 $21.85K
Cash And Equivalents Q3 2022 · Dec 31, 2021 $62
Cash And Equivalents Q3 2022 · Sep 30, 2021 $1.38K
Cash And Equivalents Q3 2022 · Dec 31, 2020 $698
Current Liabilities Q3 2022 · Sep 30, 2022 $421.64K
Current Liabilities Q3 2022 · Dec 31, 2021 $369.19K
Total Liabilities Q3 2022 · Sep 30, 2022 $421.64K
Total Liabilities Q3 2022 · Dec 31, 2021 $369.19K
Current Assets Q3 2022 · Sep 30, 2022 $21.85K
Current Assets Q3 2022 · Dec 31, 2021 $62
Total Assets Q3 2022 · Sep 30, 2022 $21.85K
Total Assets Q3 2022 · Dec 31, 2021 $62
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$11.02K
Stockholders Equity Q3 2022 · Sep 30, 2021 −$361.58K
Stockholders Equity Q3 2022 · Jun 30, 2021 −$350.61K
Stockholders Equity Q3 2022 · Mar 31, 2021 −$342.23K
Stockholders Equity Q3 2022 · Dec 31, 2020 −$332.34K
Sga Expense Q3 2022 · Sep 30, 2021 $6.32K
Sga Expense Q3 2022 · Sep 30, 2021 $15.52K
Net Income Q3 2022 · Sep 30, 2021 −$10.98K
Net Income Q3 2022 · Sep 30, 2021 −$29.24K
Net Income Q3 2022 · Jun 30, 2021 −$8.37K
Net Income Q3 2022 · Mar 31, 2021 −$9.89K
Operating Income Q3 2022 · Sep 30, 2021 −$6.32K
Operating Income Q3 2022 · Sep 30, 2021 −$15.52K